Home › Funds › Lynx1 Capital Management LP › BOLT
Lynx1 Capital Management LP position in BOLT
BOLT BIOTHERAPEUTICS INC · Health Care
Lynx1 Capital Management LP reported holding 30,800 shares of BOLT (BOLT BIOTHERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$119K, representing 0.01% of its reported portfolio and ranking #24 among its reported holdings. Lynx1 Capital Management LP has disclosed BOLT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Lynx1 Capital Management LP's BOLT position evolved
Lynx1 Capital Management LP first disclosed a stake in BOLT in Q1 2026 at 30,800 shares (US$124K). Across 2 filings, Lynx1 Capital Management LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 30,800 shares valued at US$119K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 30.80K | $124.43K | New |
| Q2 2026 | 30.80K | $118.58K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BOLT and 13F data
BOLT (BOLT BIOTHERAPEUTICS INC) is a Health Care company. 15 other funds we track also report a position in BOLT — the largest reported positions include Vivo Capital, LLC (US$279K), Board of Trustees of The Leland Stanford Junior University (US$139K), PFIZER INC (US$134K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BOLT
- Vivo Capital, LLC 72.41K sh · $278.79K · Q2 2026
- Board of Trustees of The Leland Stanford Junior University 35.98K sh · $138.51K · Q2 2026
- PFIZER INC 31.30K sh · $133.83K · Q2 2026
- Nan Fung Group Holdings Ltd 5.00K sh · $19.25K · Q2 2026
More on Lynx1 Capital Management LP
FAQ
How long has Lynx1 Capital Management LP held BOLT?
Lynx1 Capital Management LP has disclosed BOLT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Lynx1 Capital Management LP's current position in BOLT?
As of Q2 2026, Lynx1 Capital Management LP holds 30.80K shares of BOLT (BOLT BIOTHERAPEUTICS INC), valued at $118.58K, representing 0.01% of its reported portfolio and ranking #24.
Has Lynx1 Capital Management LP been buying or selling BOLT?
In the latest 13F filing (Q2 2026), Lynx1 Capital Management LP held unchanged its position in BOLT.
Which other funds hold BOLT?
Other major institutional holders of BOLT include Vivo Capital, LLC, Board of Trustees of The Leland Stanford Junior University, PFIZER INC, among 15 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.